S. Reed - Jan 7, 2022 Form 4 Insider Report for Mirati Therapeutics, Inc. (MRTX)

Signature
/s/ Elizabeth Gelfand, Attorney in Fact
Stock symbol
MRTX
Transactions as of
Jan 7, 2022
Transactions value $
-$46,900
Form type
4
Date filed
1/7/2022, 07:26 PM
Previous filing
Jan 6, 2022
Next filing
Jan 18, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction MRTX Common Stock Sale -$46.9K -345 -3.17% $135.94 10.5K Jan 7, 2022 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents shares sold by the Company to satisfy the tax withholding obligation associated with the vesting of a portion of the restricted stock units (RSUs) granted on January 6, 2020.
F2 The price is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $135.94 to $136.595, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth above.